Valiant Laboratories Stock Price Analysis and Quick Research Report. Is Valiant Laboratories an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Valiant Laboratories. 

• PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Valiant Laboratories has a PE ratio of 703.799514955538 which is high and comparatively overvalued.

• Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Valiant Laboratories has ROA of 0.1266% which is a bad sign for future performance. (Higher values are always desirable.)

• Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Valiant Laboratories has a Current ratio of 7.9376.

• Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Valiant Laboratories has a ROE of 0.2017%. (Higher is better)

• Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Valiant Laboratories has a Debt to Equity ratio of 0.2508 which means that the company has low proportion of debt in its capital.

• Sales growth: Valiant Laboratories has reported revenue growth of -45.4785% which is poor in relation to its growth and performance. 

• Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Valiant Laboratories for the current financial year is -4.61943923837314%.

• Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Valiant Laboratories is Rs 0 and the yield is 0%.

• Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Valiant Laboratories is Rs 0.1237. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Valiant Laboratories in Ticker for free. Also, one can get the intrinsic value of Valiant Laboratories by using Valuation Calculators, which are available with a Finology ONE subscription. 

Valiant Laboratories FAQs

Q1. What is Valiant Laboratories share price today?
Ans: The current share price of Valiant Laboratories is Rs 87.06.

Q2. What is the market capitalisation of Valiant Laboratories?
Ans: Valiant Laboratories has a market capitalisation of Rs 472.844625 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Valiant Laboratories?
Ans: The PE ratio of Valiant Laboratories is 703.799514955538 and the P/B ratio of Valiant Laboratories is 1.48848246938318, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Valiant Laboratories share?
Ans: The 52-week high share price of Valiant Laboratories is Rs 122.409957081545, and the 52-week low share price of Valiant Laboratories is Rs 69.8424034334764.

Q5. Does Valiant Laboratories pay dividends?
Ans: Currently, Valiant Laboratories does not pay dividends. Dividend yield of Valiant Laboratories is around 0%.

Q6. What are the face value and book value of Valiant Laboratories shares?
Ans: The face value of Valiant Laboratories shares is Rs 10, while the book value per share of Valiant Laboratories is around Rs 58.4891. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Valiant Laboratories?
Ans: Valiant Laboratories has a total debt of Rs 59.4002 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Valiant Laboratories?
Ans: The ROE of Valiant Laboratories is 0.2017% and ROCE of Valiant Laboratories is -0.2958%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Valiant Laboratories a good buy for the long term?
Ans: The Valiant Laboratories long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Valiant Laboratories undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Valiant Laboratories appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Valiant Laboratories’s financials?
Ans: You can review Valiant Laboratories’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.